How many insider declarations has Skvarka Jan filed?

Skvarka Jan has filed 7 public insider declarations with SEC (Form 4).

What is Skvarka Jan's role?

Skvarka Jan's reported role is not specified by the regulator across the filings.

Which companies does Skvarka Jan report trades for?

Skvarka Jan reports trades for 2 companies, including Trillium Therapeutics Inc..

What is Skvarka Jan's declared buy vs sell volume?

Across the available history, declared buys total 99k€ and disposals 116k€.

← Executives ★ Sign in to follow

SJ

Skvarka Jan

Other

US·SEC (Form 4)

Trillium Therapeutics Inc.Zentalis Pharmaceuticals, Inc.

Cumul. flow

0

Total declarations

0

Companies

€99,493

▲ Purchases (1 ops.)

€116,496

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

1

Disclosed sells

1

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Discover the full record of transactions filed by Skvarka Jan. Officer active across 2 companies, notably Trillium Therapeutics Inc.. Cumulatively, 7 disclosures have been recorded. Split: 1 buy · 1 sell. Total volume traded: €216k. History available since 11 May 2021. The latest transaction was disclosed on 31 January 2025 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Declarations7 total

▲

Skvarka Jan

DirectorExecutives31 Jan 2025Zentalis Pharmaceuticals, Inc.

$103,44634SEC ↗

60,000 shares@ US$1.724146.1% of flowCommon StockSEC:0001725160-25-000030:0